|
Medication Safety News - Preventing Medication Errors
Risk Calculators - Check Risk for Medication Errors
Consumermedsafety.org: ISMP Drug Alerts
MedlinePlus Health News
FDA: What's New Drugs - Ask our Clinical Pharmacists
- Initiative Partners
- New and Generic Drug Approvals
Drug Approval Listing
- Orange Book FR Safety or Effectiveness Determinations List (PDF)
updated 2/3/2012.
- Medication Guides
Updated list of medication guides.
- Current Drug Shortages
New/Updated Drug Shortages: Ondansetron Injection 2 mg/mL, Tobramycin Solution for Injection, Morphine Sulfate Injection, Midazolam Injection, Methotrexate Injection, Magnesium Sulfate Injection, Lorazepam Injection, Labetalol Hydrochloride Injection, Ketorolac Injection, Furosemide Injection, Diltiazem Injection, Bupivacaine Hydrochloride Injection, Primaquine Phosphate Tablets, Desmopressin Injection 2/2/2012
- Newly Added Guidance Documents
- Pediatric Exclusivity Granted
Updated statistics and exclusivity determinations list.
- Drugs@FDA Data Files
Data files updated through January 11, 2012.
- Warning Letters 2011
Letters added
- FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
[01-20-2012] The U.S. Food and Drug Administration (FDA) is informing the public that testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for progressive multifocal leukoencephalopathy (PML).
FDA: Consumer Health Information - Any Medicine Questions?
- Consumer Update Analytics
This page contains links to all past Consumer Update Analytics web pages.
- FDA's MedWatch Safety Alerts: December 2011
FDA gives updated safety information on ADHD drugs and heart disease in adults, dietary supplements that could be contaminated with Salmonella, and a blood thinner that may lead to bleeding problems. Learn about these and other safety alerts at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucmXXXXXX.htm
- Jan. 18 Webinar: Reporting Bad Reactions From Cosmetics
Learn how to report a bad reaction to a beauty, personal hygiene or makeup product. Click here to find out how to connect to this 30-minute webinar.
- FDA Warns About Stem Cell Claims
Don't be fooled by unscrupulous people who offer hope through unapproved stem cell therapies for diseases or conditions for which few treatments exist.
- FDA Targets Risks From Reused Medical Devices
The Food and Drug Administration is taking steps to ensure that reusable medical devices, especially endoscopes, are properly cleaned and disinfected to reduce the risk of infection.
- FDA's MedWatch Safety Alerts: November 2011
FDA warns about a home massager that has caused a death, and gives updated safety information on ADHD drugs and heart disease in children, and TNF blocker drugs that have been linked to reports of cancer. Learn about these safety alerts and others: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm283962.htm
- Know Concentration Before Giving Acetaminophen to Infants
FDA is urging consumers to examine the labels of liquid infant's acetaminophen to avoid giving the wrong dose as a less concentrated form of the popular medicine arrives in stores.
- FDA Targets Gastric Band Weight-Loss Claims
Beware of ads that glamorize this surgery without giving the risks. Learn more at www.fda.gov/ForConsumers/ConsumerUpdates/ucm279301.htm
- FDA Widens Look at Arsenic in Apple Juice
FDA is enhancing its surveillance of arsenic in apple juice while remaining confident in the overall safety of this juice for consumers.
- FDA and Partners Working to Prevent Surgical Fires
The Food and Drug Administration (FDA) is building a coalition of public and private healthcare organizations to prevent a medical error - the surgical fire.
FDA: MedWatch Safety Alerts (Human Medical Products)
- Gris-PEG (griseofulvin ultramicrosize): Health Advisory - Risk of Product Mix-Up
During packaging and labeling, tablets from one product type may have carried over into packaging of another product.
- Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall - Visible Glass Particle
Use of an inhaled product with glass particles has the potential to cause choking which could be life-threatening.
- Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall - Possibility of Inexact Tablet Counts or Out of Sequence Tablets
Oral contraceptive daily regimen may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy.
- Vitaflo USA Renastart: Recall - Possible Health Risk Due To Incorrectly Labeled Cans
Consequences of using the incorrectly labeled product may result in high potassium blood levels (hyperkalemia) or high sodium levels in the blood (hypernatremia).
- Treanda (bendamustine HCL): Recall - Particulate Matter in Vial
Potential adverse events after intravenous administration of solutions containing particulates may include emboli and result in disruption of blood flow, causing tissue/organ damage.
- Tysabri (natalizumab): Drug Safety Communication - New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML)
The risks and benefits of continuing treatment with Tysabri should be carefully considered in patients who are found to be anti-JCV antibody positive and have one or more of the other known risk factors for PML.
- Perfect Image Solutions Topical Hair Regrowth Products: Recall - Unapproved Drugs, Risk of Health Hazards
Systemic absorption of topically administered Minoxidil could cause low blood pressure, heart palpitations and associated cardiac symptoms.
- Vagifresh Ball, Vagifresh Gel, Female One: Recall - Undeclared Drug Ingredient, Bacterial Contamination
Possibility of an adverse reaction or unknown drug-drug interaction.
- Adcetris (brentuximab vedotin): Drug Safety Communication - Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity
New Boxed Warning and Contraindication highlighting these risks added to product labeling.
- CardioGen-82 PET Scan: Drug Safety Communication - Increased Radiation Exposure
UPDATED 01/12/2012. FDA is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary recall of CardioGen-82.
Reuters: Health News - Create a Medication List
- Cancer survivors line up as opponents in Super Bowl
INDIANAPOLIS (Reuters) - There can only be one winner in Sunday's Super Bowl but for two opposing players, a bigger battle has already been won, victory over cancer.
- Parents urge more tests as twitches spread at New York school
LE ROY, New York (Reuters) - State health officials have added three more names to a growing list of students in this working-class town who are experiencing mysterious tics and twitching, while authorities on Saturday sought to assure parents the community's high school is safe.
- Komen reverses move to cut Planned Parenthood funding
WASHINGTON (Reuters) - The Susan G. Komen for the Cure foundation backed down from its decision to cut funding for Planned Parenthood, which provides abortion and birth control services, following a massive outcry by supporters of the world's largest breast cancer charity.
- Malaria kills twice as many as thought: study
LONDON (Reuters) - Malaria kills more than 1.2 million people worldwide a year, nearly twice as many as previously thought, according to new research published on Friday that questions years of assumptions about the mosquito-borne disease.
- Nerve disorder does not recur after later vaccines: study
NEW YORK (Reuters Health) - Despite concerns by some that vaccines might cause a crippling nerve disorder called Guillain-Barré syndrome, a new study finds that people who receive vaccines after previously having been diagnosed with the condition do not experience any flare-ups.
- Bossy mom at snack time tied to kid's weight: study
(Reuters) - Mothers who push their toddlers to eat more at snack time may end up with slightly chubbier children by the age of three, according to a U.S. study.
- Green tea drinkers show less disability with age: study
NEW YORK (Reuters Health) - Elderly adults who regularly drink green tea may stay more agile and independent than their peers over time, a large study of Japanese adults suggests.
- Anxiety therapy doesn't work as well in elderly: study
NEW YORK (Reuters Health) - A form of talk therapy called cognitive behavioral therapy appears to help older adults battle anxiety disorders slightly better than other approaches, but not as well as in younger adults, according to a new study.
- Breastfeeding tied to stronger lungs, less asthma
NEW YORK (Reuters Health) - Kids who were breastfed as babies may have better lung function, and a lower risk of asthma, than those who were formula-fed, two new reports suggest.
- Traffic-related asthma costs two cities big money
NEW YORK (Reuters Health) - Traffic pollution may cost two California cities millions each year in managing children's asthma, a new study suggests.
|
